Technology Industry
Industry: Email Alert RSS FeedNovalon Pharmaceutical Corp
BT Catalyst, Sept, 1999
Novalon Pharmaceutical Corp. of Durham and Ares-Serono of Switzerland have entered into a research agreement under which Novalon will develop screening assays for Ares-Serono. Novalon will receive research and milestone payments for developing target assays, and royalty payments for any future products.
- Most Popular Articles in Technology
- An overview of continuous data protection
- Why all those current ratings?
- Many countries now have a mobile penetration rate above 100%, report says
- The Tata Group's big telecom gamble: VSNL's recent acquisition of Tyco ...
- MEASURING BANK BRANCH EFFICIENCY USING DATA ENVELOPMENT ANALYSIS: MANAGERIAL ...
- More »
COPYRIGHT 1999 North Carolina Biotechnology Center
COPYRIGHT 2008 Gale, Cengage Learning